Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid (11C-PABA)

NCT05611905 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05611905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid (11C-PABA)
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Completed
Start date
December 22, 2023
Completion date
November 8, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, inflammatory disease, oncologic disease, renal excretion